Mediadvance Clinical S.A.P.I de C.V.

The trials here

What the 9 trials at this site are about, from their registry records.

Conditions

• Bronchiectasis4 trials
• Systemic sclerosis (scleroderma)2 trials
• Asthma1 trial
• Dermatomyositis and polymyositis (myositis)1 trial
• Lupus (SLE)1 trial

Phase

• Phase 35 trials
• Phase 24 trials

Status

• Not yet recruiting4 trials
• Completed3 trials
• Active, not recruiting2 trials

Lead sponsor

• Boehringer Ingelheim7 trials
• argenx1 trial
• Teva Branded Pharmaceutical Products R&D LLC1 trial

Running trials

• Not yet recruiting

  A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)

  NCT07915219· Phase 3· Boehringer Ingelheim· Source

  Contact: Boehringer Ingelheim

• Not yet recruiting

  A Study to Understand How Nerandomilast Works in People With Active Idiopathic Inflammatory Myopathies

  NCT07789015· Phase 3· Boehringer Ingelheim· Source

  Contact: Boehringer Ingelheim

• Recruiting

  A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

  NCT07497087· Phase 3· Boehringer Ingelheim· Source

  Contact: Boehringer Ingelheim

• Recruiting

  A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)

  NCT07409181· Phase 2· Boehringer Ingelheim· Source

  Contact: Boehringer Ingelheim

• Active, not recruiting

  A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis

  NCT06655155· Phase 2· argenx· Source

• Active, not recruiting

  Clairleafᵀᴹ: A Study to Test Long-term Treatment With BI 1291583 in People With Bronchiectasis Who Took Part in a Previous Study With This Medicine

  NCT05846230· Phase 2· Boehringer Ingelheim· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Bronchiectasis1 recruiting
• Dermatomyositis and polymyositis (myositis)1 recruiting
• Lupus (SLE)1 recruiting
• Systemic sclerosis (scleroderma)1 recruiting

Closed trials

• Recruiting

  The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis

  NCT06872892· Phase 3· Boehringer Ingelheim· Source

  Contact: Boehringer Ingelheim

• Completed

  A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma

  NCT06664619· Phase 3· Teva Branded Pharmaceutical Products R&D LLC· Source

• Completed

  A Study to Test Whether Different Doses of BI 1291583 Help People With Bronchiectasis

  NCT05238675· Phase 2· Boehringer Ingelheim· Source